Phase Forward Inc. had a pretty good run during the three months ended June 30, posting healthy sales and earnings increases and making a pair of acquisitions to broaden its portfolio of offerings.
The Waltham, Mass.-based clinical trial data management provider posted second-quarter sales of $52.5 million, up 29 percent compared with sales of $40.9 million during the same period last year.